*BrainsWay Deep TMS is not FDA-cleared to treat addiction behaviors. This webinar covers the results of clinical research being conducted
![]() |
Abraham Zangen, PhDCo-Founder |
Professor Abraham Zangen is the Head of the Brain Stimulation and Behavior Lab and the Chair of the PsychoBiology Brain Program at Ben-Gurion University in Israel. His research is directed at identifying and understanding altered neuroplasticity in psychiatric disorders – primarily depression, addiction and ADHD. Prof. Zangen has published over 150 peer reviewed articles, reviews and book chapters.